Results 1 to 10 of about 251,619 (354)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances [PDF]

Brain Sciences, 2020
Objective: This survey aimed to explore knowledge and experience on novel psychoactive substances (NPS) of healthcare professionals (HCPs). The study also aimed to assess how HCPs would like to improve their knowledge of NPS.
Camille Ramos, Amira Guirguis, Nigel Smeeton, Hadar Zaman, Anna-Marie Felice, Stephanie Bancroft, Rosalind Gittins, Gill Hawksworth, John Martin Corkery, Fabrizio Schifano   +9 more
doaj   +5 more sources

Impact of a Hybrid Prevention Program for High School Students on Prescription Drug Misuse Outcomes [PDF]

Behavioral Sciences
Prescription drug misuse among youth is a significant public health problem that can lead to negative consequences, including addiction and overdose deaths.
Kenneth W. Griffin, Christopher Williams, Sandra M. Sousa, Gilbert J. Botvin   +3 more
doaj   +2 more sources

Early-onset prescription drug misuse in Indiana youth. [PDF]

Addict Behav, 2023
Parker MA, Zapolski TC, Carson I, Waldron MC.   +3 more
europepmc   +3 more sources

College-based social and situational predictors of real-time prescription drug misuse in daily life. [PDF]

Drug Alcohol Depend, 2021
Kouros CD, Papp LM, Kelly BC, Blumenstock SM.   +3 more
europepmc   +3 more sources

College students' momentary stress and prescription drug misuse in daily life: Testing direct links and the moderating roles of global stress and coping. [PDF]

Stress Health, 2023
Papp LM, Kouros CD, Armstrong L, Curtin JJ.   +3 more
europepmc   +2 more sources

Workplace access, burnout, and prescription drug misuse among Korean hospital nurses: a cross-sectional study. [PDF]

BMC Nurs
Kim C, Han K, Trinkoff AM, Baek H.
europepmc   +3 more sources

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Brain Sciences, 2023
The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano   +7 more
doaj   +1 more source

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Frontiers in Psychiatry, 2021
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani, Davide Arillotta, John Martin Corkery, Amira Guirguis, Amira Guirguis, Alessandro Vento, Alessandro Vento, Alessandro Vento, Fabrizio Schifano   +8 more
doaj   +1 more source

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis

Brain Sciences, 2021
The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano   +4 more
doaj   +1 more source

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity

Pharmaceuticals, 2021
Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano   +6 more
doaj   +1 more source